Automated real-world data integration improves cancer outcome predictionJustin Jee, Rona Yaeger, Mehnaj Ahmed et al.|Nature|2024Cited by 148
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M. Huffman, Samuel J. Klempner, Vasily N. Aushev et al.|JCO Precision Oncology|2022Cited by 72
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric CancerSteven B. Maron, Yelena Y. Janjigian|Clinical Cancer Research|2023Cited by 29
Predicting response to immune checkpoint blockade therapy among mismatch repair-deficient patients using mutational signaturesD. Gulhan, Peter J. Park, Vinay Viswanadham et al.|medRxiv|2024Cited by 4
RETRACTED: Circulating tumor DNA status to direct adjuvant immunotherapy for mismatch repair deficient tumorsYelena Y. Janjigian, Luis A. Díaz, Melissa Lumish et al.|Research Square|2025Cited by 0